Letter: improved parsimony of genetic risk scores for coeliac disease through refined HLA modelling

Michael Erlichster; Justin Bedo; Efstratios Skafidas; Patrick Kwan; Adam Kowalczyk; Benjamin Goudey

doi:10.1111/apt.16263

Letter: improved parsimony of genetic risk scores for coeliac disease through refined HLA modelling

Michael Erlichster, Justin Bedo, Efstratios Skafidas, Patrick Kwan, Adam Kowalczyk, Benjamin Goudey

Department of Neuroscience

Research output: Contribution to journal › Letter › Other › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	759-760
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	53
Issue number	6
DOIs	https://doi.org/10.1111/apt.16263
Publication status	Published - Mar 2021

Access to Document

10.1111/apt.16263

Cite this

@article{77162c33c2b649ce928734ab19ead992,

title = "Letter: improved parsimony of genetic risk scores for coeliac disease through refined HLA modelling",

author = "Michael Erlichster and Justin Bedo and Efstratios Skafidas and Patrick Kwan and Adam Kowalczyk and Benjamin Goudey",

note = "Funding Information: This research has been conducted using the UK Biobank Resource (application 51064). Declaration of personal interests: ME is an employee of MX3 Diagnostics. ES is a director and shareholder of MX3 diagnostics. AK is an employee of Diversity Arrays. BG is an employee of IBM Research Australia. These organisations did not influence the design, conduct, findings or publication of this research. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = mar,

doi = "10.1111/apt.16263",

language = "English",

volume = "53",

pages = "759--760",

journal = "Alimentary Pharmacology & Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Letter

T2 - improved parsimony of genetic risk scores for coeliac disease through refined HLA modelling

AU - Erlichster, Michael

AU - Bedo, Justin

AU - Skafidas, Efstratios

AU - Kwan, Patrick

AU - Kowalczyk, Adam

AU - Goudey, Benjamin

N1 - Funding Information: This research has been conducted using the UK Biobank Resource (application 51064). Declaration of personal interests: ME is an employee of MX3 Diagnostics. ES is a director and shareholder of MX3 diagnostics. AK is an employee of Diversity Arrays. BG is an employee of IBM Research Australia. These organisations did not influence the design, conduct, findings or publication of this research. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/3

Y1 - 2021/3

UR - http://www.scopus.com/inward/record.url?scp=85100972797&partnerID=8YFLogxK

U2 - 10.1111/apt.16263

DO - 10.1111/apt.16263

M3 - Letter

C2 - 33599319

AN - SCOPUS:85100972797

VL - 53

SP - 759

EP - 760

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

SN - 0269-2813

IS - 6

ER -

Letter: improved parsimony of genetic risk scores for coeliac disease through refined HLA modelling

Access to Document

Other files and links

Cite this